Los Angeles Capital Management’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.9K | Hold |
58
| – | – | ﹤0.01% | 1712 |
|
|
2025
Q4 | $26.4K | Buy |
+58
| New | +$25.2K | ﹤0.01% | 1788 |
|
|
2024
Q4 | – | Sell |
-17,723
| Closed | -$10.7M | – | 1131 |
|
|
2024
Q3 | $10.7M | Buy |
17,723
+4,136
| +30% | +$2.34M | 0.04% | 246 |
|
|
2024
Q2 | $7.37M | Sell |
13,587
-28,125
| -67% | -$16.1M | 0.03% | 291 |
|
|
2024
Q1 | $26.8M | Buy |
+41,712
| New | +$25.3M | 0.09% | 187 |
|
|
2023
Q3 | – | Sell |
-10,932
| Closed | -$5.92M | – | 1134 |
|
|
2023
Q2 | $5.92M | Sell |
10,932
-1,319
| -11% | -$721K | 0.02% | 311 |
|
|
2023
Q1 | $6.59M | Sell |
12,251
-248
| -2% | -$126K | 0.03% | 315 |
|
|
2022
Q4 | $6.38M | Buy |
12,499
+2,102
| +20% | +$1.02M | 0.03% | 345 |
|
|
2022
Q3 | $4.54M | Sell |
10,397
-1,109
| -10% | -$533K | 0.02% | 375 |
|
|
2022
Q2 | $5.4M | Sell |
11,506
-1,090
| -9% | -$532K | 0.03% | 351 |
|
|
2022
Q1 | $6.38M | Sell |
12,596
-10
| -0.1% | -$4.8K | 0.03% | 331 |
|
|
2021
Q4 | $6.67M | Sell |
12,606
-17,704
| -58% | -$8.5M | 0.02% | 315 |
|
|
2021
Q3 | $14.1M | Sell |
30,310
-1,225
| -4% | -$578K | 0.06% | 233 |
|
|
2021
Q2 | $15M | Buy |
31,535
+5,927
| +23% | +$2.85M | 0.07% | 242 |
|
|
2021
Q1 | $11.8M | Sell |
25,608
-18,669
| -42% | -$9.15M | 0.05% | 281 |
|
|
2020
Q4 | $23.6M | Sell |
44,277
-2,698
| -6% | -$1.33M | 0.1% | 181 |
|
|
2020
Q3 | $22.6M | Sell |
46,975
-56,909
| -55% | -$27.9M | 0.1% | 157 |
|
|
2020
Q2 | $46.9M | Buy |
103,884
+1,739
| +2% | +$776K | 0.23% | 102 |
|
|
2020
Q1 | $44.2M | Sell |
102,145
-3,230
| -3% | -$1.44M | 0.28% | 90 |
|
|
2019
Q4 | $46.3M | Buy |
105,375
+2,254
| +2% | +$948K | 0.23% | 111 |
|
|
2019
Q3 | $43.1M | Buy |
103,121
+37,340
| +57% | +$15.2M | 0.23% | 111 |
|
|
2019
Q2 | $23.7M | Sell |
65,781
-610
| -0.9% | -$204K | 0.13% | 181 |
|
|
2019
Q1 | $21.3M | Buy |
66,391
+55,120
| +489% | +$16.9M | 0.12% | 182 |
|
|
2018
Q4 | $3.19M | Buy |
11,271
+538
| +5% | +$162K | 0.02% | 450 |
|
|
2018
Q3 | $3.43M | Sell |
10,733
-1,040
| -9% | -$331K | 0.02% | 527 |
|
|
2018
Q2 | $3.79M | Sell |
11,773
-4,960
| -30% | -$1.55M | 0.02% | 537 |
|
|
2018
Q1 | $4.57M | Buy |
16,733
+54
| +0.3% | +$14.3K | 0.03% | 451 |
|
|
2017
Q4 | $4.05M | Buy |
16,679
+5,985
| +56% | +$1.36M | 0.02% | 493 |
|
|
2017
Q3 | $2.16M | Buy |
10,694
+4,160
| +64% | +$818K | 0.01% | 598 |
|
|
2017
Q2 | $1.34M | Hold |
6,534
| – | – | 0.01% | 694 |
|
|
2017
Q1 | $1.19M | Buy |
6,534
+1,188
| +22% | +$207K | 0.01% | 673 |
|
|
2016
Q4 | $858K | Hold |
5,346
| – | – | 0.01% | 743 |
|
|
2016
Q3 | $754K | Sell |
5,346
-290
| -5% | -$40.4K | 0.01% | 798 |
|
|
2016
Q2 | $768K | Hold |
5,636
| – | – | 0.01% | 785 |
|
|
2016
Q1 | $763K | Buy |
5,636
+350
| +7% | +$47.3K | 0.01% | 702 |
|
|
2015
Q4 | $792K | Hold |
5,286
| – | – | 0.01% | 728 |
|
|
2015
Q3 | $706K | Buy |
+5,286
| New | +$740K | 0.01% | 780 |
|
|
2013
Q3 | – | Sell |
-10,045
| Closed | -$728K | – | 1307 |
|
|
2013
Q2 | $728K | Buy |
+10,045
| New | +$737K | 0.01% | 769 |
|
Other funds holding CHE
VPM
VCM
Los Angeles Capital Management's CHE Position: Q1 2026 in Review
Los Angeles Capital Management held its Chemed (CHE) position steady in Q1 2026 at 58 shares worth $21.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1712.
Los Angeles Capital Management first reported a position in CHE in Q2 2013 and has held it in 38 quarters since. The position peaked at $46.9M in Q2 2020. 488 funds tracked by Wall St. Rank hold CHE as of Q1 2026.
- Los Angeles Capital Management held 58 shares of Chemed worth $21.9K as of Q1 2026.
- Los Angeles Capital Management left its Chemed share count unchanged in Q1 2026.
- Chemed made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1712 holding.
- Los Angeles Capital Management first reported a position in Chemed in Q2 2013 and has held it in 38 quarters since.
- Los Angeles Capital Management's Chemed position peaked at $46.9M in Q2 2020.
- 488 funds tracked by Wall St. Rank held Chemed as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.